TW202528333A - 犬口服疫苗及投與方法 - Google Patents

犬口服疫苗及投與方法

Info

Publication number
TW202528333A
TW202528333A TW113140325A TW113140325A TW202528333A TW 202528333 A TW202528333 A TW 202528333A TW 113140325 A TW113140325 A TW 113140325A TW 113140325 A TW113140325 A TW 113140325A TW 202528333 A TW202528333 A TW 202528333A
Authority
TW
Taiwan
Prior art keywords
oral vaccine
canine
recombinant
vaccine
modified live
Prior art date
Application number
TW113140325A
Other languages
English (en)
Chinese (zh)
Inventor
基斯 艾倫 亞美斯
育剛 羅
毛羅 皮雷斯 莫拉伊斯
雪倫 瑪莉 瓦佩爾
Original Assignee
美商碩騰服務有限責任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商碩騰服務有限責任公司 filed Critical 美商碩騰服務有限責任公司
Publication of TW202528333A publication Critical patent/TW202528333A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TW113140325A 2023-10-24 2024-10-23 犬口服疫苗及投與方法 TW202528333A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363592672P 2023-10-24 2023-10-24
US63/592,672 2023-10-24

Publications (1)

Publication Number Publication Date
TW202528333A true TW202528333A (zh) 2025-07-16

Family

ID=93432252

Family Applications (1)

Application Number Title Priority Date Filing Date
TW113140325A TW202528333A (zh) 2023-10-24 2024-10-23 犬口服疫苗及投與方法

Country Status (3)

Country Link
AR (1) AR134175A1 (fr)
TW (1) TW202528333A (fr)
WO (1) WO2025090476A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0979101B1 (fr) * 1996-07-03 2010-10-27 Merial, Inc. ADENOVIRUS CANIN 2 RECOMBINANT (ACR2) CONTENANT DE l'ADN EXOGENE
CA2650730A1 (fr) 2006-04-27 2007-11-08 Pikamab, Inc. Procedes et compositions pour la therapie par anticorps
CA2674026C (fr) 2006-12-27 2018-08-21 Pfizer Products Inc. Procedes d'administration de vaccin
WO2018057441A1 (fr) * 2016-09-20 2018-03-29 Boehringer Ingelheim Vetmedica Gmbh Vecteurs d'adénovirus canin

Also Published As

Publication number Publication date
WO2025090476A1 (fr) 2025-05-01
AR134175A1 (es) 2025-12-10

Similar Documents

Publication Publication Date Title
JP6845266B2 (ja) 多価組換型鳥ヘルペスウイルス及び鳥類を免疫化するためのワクチン
CN104159604B (zh) 表达禽类病原体的抗原的重组hvt载体及其用途
JP6913747B2 (ja) イヌアデノウイルスベクター
CN102573901B (zh) 重组禽副粘病毒疫苗及其制备和使用方法
US9096869B2 (en) Recombinant nonpathogenic MDV vector providing multivalent immunity
JP6951429B2 (ja) 新規のブタインフルエンザワクチン
US20200030438A1 (en) Vaccine against porcine parvovirus
EP0551449A1 (fr) Procede de production d'un vaccin sous-unitaire contre le parvovirus porcin
CN114828882A (zh) 多价hvt载体疫苗
WO2019057859A1 (fr) Système d'expression de paramyxoviridae
US10548967B2 (en) Attenuated swine influenza vaccines and methods of making and use thereof
JP7245260B2 (ja) Ｅｈｖ挿入部位ｕｌ４３
TW202528333A (zh) 犬口服疫苗及投與方法
CN102641499A (zh) 口蹄疫病毒vp1基因重组小反刍兽疫病毒活载体疫苗构建及应用
AU2024368291A1 (en) Canine oral vaccines and methods of administration
CN1258596C (zh) 基于野兔痘的载体疫苗
EP4240836A1 (fr) Parvovirus canin
HK40077732A (en) Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
WO2022269362A2 (fr) Vecteur viral vétérinaire
Basavarajappa Improved infectious laryngotracheitis virus vaccines using Newcastle disease virus vector
HK40021345A (en) Recombinant gallid herpesvirus 3 (mdv serotype 2) vectors expressing antigens of avian pathogens and uses thereof
HK40017399A (en) Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
HK1247832B (en) Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof